1. Home
  2. TR vs OGN Comparison

TR vs OGN Comparison

Compare TR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tootsie Roll Industries Inc.

TR

Tootsie Roll Industries Inc.

HOLD

Current Price

$43.01

Market Cap

3.1B

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.14

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TR
OGN
Founded
1896
1923
Country
United States
United States
Employees
2100
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
1.5B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
TR
OGN
Price
$43.01
$6.14
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$11.75
AVG Volume (30 Days)
117.9K
3.0M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
0.84%
1.34%
EPS Growth
N/A
N/A
EPS
N/A
0.72
Revenue
N/A
$6,216,000,000.00
Revenue This Year
N/A
$0.42
Revenue Next Year
N/A
$1.67
P/E Ratio
$32.36
$8.31
Revenue Growth
N/A
N/A
52 Week Low
$29.13
$5.69
52 Week High
$44.27
$14.70

Technical Indicators

Market Signals
Indicator
TR
OGN
Relative Strength Index (RSI) 61.31 39.63
Support Level $40.07 N/A
Resistance Level $43.37 $7.87
Average True Range (ATR) 1.26 0.24
MACD 0.06 0.03
Stochastic Oscillator 75.14 51.79

Price Performance

Historical Comparison
TR
OGN

About TR Tootsie Roll Industries Inc.

Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: